Rare monosomy 7 and deletion 7p at diagnosis of chronic myeloid leukemia in accelerated phase

Poor prognosis of chromosome 7 clonal aberrations in Philadelphia-negative metaphases and relevance of potential underlying myelodysplastic features in chronic myeloid leukaemia.

(2018) Audrey Bidet et al.   HAEMATOLOGICA

Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy

(2016) W. Wang et al.   BLOOD

Clinical significance of trisomy 8 that emerges during therapy in chronic myeloid leukemia

(2016) W Wang et al.   Blood Cancer Journal

Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)

(2013) E. Jabbour et al.   BLOOD

Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis

(2012) S. Luatti et al.   BLOOD

How I treat CML blast crisis

(2012) R. Hehlmann   BLOOD

First-line imatinib mesylate in patients with newly diagnosed accelerated phase-chronic myeloid leukemia

(2012) D Rea et al.   LEUKEMIA

Chronic myeloid leukemia: mechanisms of blastic transformation

(2010) Danilo Perrotti et al.   JOURNAL OF CLINICAL INVESTIGATION